RCS - Eco Animal Health Gp - ESG Rating

ECO Animal HealthAnnouncement

28/09/2023 07:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20230928:nRSb8774Na&default-theme=true

RNS Number : 8774N  Eco Animal Health Group PLC  28 September 2023

28 September 2023

ECO Animal Health Group plc

(''ECO", the "Company" or the "ECO Group")

(AIM: EAH)

ESG Rating

 

ECO Animal Health Group plc, a leader in the development, registration and
marketing of pharmaceutical products for global animal health markets, is
pleased to announce that it has achieved an A-rating for its ESG activities
from Integrum ESG, who provide independent ESG ratings to a large number of
companies.

 

An 'A' rating is the highest score possible and higher than approximately 300
other companies ranked in the same sub-sector. The rating reflects the ECO ESG
strategy and activities and metrics, which are focused especially on
environmental and social, particularly ethnic and gender diversity, aspects.

 

David Hallas, CEO commented: "ECO is committed to embedding sustainability
into the high standards set for its business dealings. We recognise the value
of incorporating the principles of Environment, Social and Governance (ESG)
into everything we do and aspire to contribute to six of the UN SDGs which are
aligned with our current and future business and intentions."

 

 

For further information please contact:

 ECO Animal Health Group plc                                     020 8447 8899

 David Hallas (CEO)

 Christopher Wilks (CFO)

 IFC Advisory                                                    020 3934 6630

 Graham Herring

 Zach Cohen

 Singer Capital Markets (Nominated Adviser & Joint Broker)       020 7496 3000

 Phil Davies

 Sam Butcher

 Investec (Joint Broker)                                         020 7597 5970

 Gary Clarence

 Lydia Zychowska

 Carlo Spingardi

 

 Equity Development  020 7065 2692

 Hannah Crowe

 Matt Evans

 

About ECO Animal Health

ECO Animal Health Group plc researches, develops and commercialises products
for livestock. Our business strategy is to generate shareholder value by
achieving the maximum sales potential from the existing product portfolio
whilst investing in Research and Development ("R&D") for new products,
particularly vaccines, and seeking to in-license new products.

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  NRALRMJTMTTTBRJ